These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8275032)

  • 1. Serum cytokine levels in patients undergoing bone marrow transplantation.
    Chasty RC; Lamb WR; Gallati H; Roberts TE; Brenchley PE; Yin JA
    Bone Marrow Transplant; 1993 Oct; 12(4):331-6. PubMed ID: 8275032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble tumor necrosis factor (sTNF) receptors: a possible prognostic marker for bone marrow transplantation-related complications.
    Or R; Kalinkovich A; Nagler A; Weisman Z; Naparstek E; Weiss L; Hahn T
    Cytokines Mol Ther; 1996 Dec; 2(4):243-50. PubMed ID: 9384711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.
    Ferrà C; de Sanjosé S; Gallardo D; Berlanga JJ; Rueda F; Marìn D; de la Banda E; Ancìn I; Peris J; Garcìa J; Grañena A
    Haematologica; 1998 Dec; 83(12):1082-7. PubMed ID: 9949625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.
    Imamura M; Hashino S; Kobayashi H; Kubayashi S; Hirano S; Minagawa T; Tanaka J; Fujii Y; Kobayashi M; Kasai M
    Bone Marrow Transplant; 1994 Jun; 13(6):745-51. PubMed ID: 7920309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation.
    Schots R; Kaufman L; Van Riet I; Ben Othman T; De Waele M; Van Camp B; Demanet C
    Leukemia; 2003 Jun; 17(6):1150-6. PubMed ID: 12764383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of soluble low affinity IL2 receptors (s-IL2 R) and TNF in the serum after BMT.
    Alessandrino EP; Bernasconi P; Colombo A; Boni M; Bonfichi M; Caldera D; Bernasconi C
    Bone Marrow Transplant; 1991; 7 Suppl 2():51. PubMed ID: 1878716
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum interleukin-6 levels during bone marrow transplantation: impact on transplant-related toxicity and engraftment.
    Steffen M; Dürken M; Pichlmeier U; von dem Busche C; Stockschläder M; Krüger W; Budde-Steffen C; Zander A
    Bone Marrow Transplant; 1996 Aug; 18(2):301-7. PubMed ID: 8864438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality.
    Schots R; Kaufman L; Van Riet I; Lacor P; Trullemans F; De Waele M; Van Camp B
    Bone Marrow Transplant; 1998 Jul; 22(1):79-85. PubMed ID: 9678800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of interleukin-6, tumour necrosis factor-alpha, and C-reactive protein in patients undergoing major operations.
    Kragsbjerg P; Holmberg H; Vikerfors T
    Eur J Surg; 1995 Jan; 161(1):17-22. PubMed ID: 7727600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
    Remberger M; Ringdén O
    Transplantation; 1995 Dec; 60(11):1293-9. PubMed ID: 8525524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation.
    Bonnotte B; Burdiles AM; Chehimi J; Carayol G; Pardoux C; Dietrich PY; Kubin M; Blay JY; Caignard A; Ibrahim A; Robinet E; Hayat M; Pico JL; Bourhis JH; Chouaib S
    Eur Cytokine Netw; 1996 Sep; 7(3):389-94. PubMed ID: 8954182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation.
    Hempel L; Körholz D; Nussbaum P; Bönig H; Burdach S; Zintl F
    Bone Marrow Transplant; 1997 Sep; 20(5):365-8. PubMed ID: 9339750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of correlation between serum levels and receptor expression of TNF alpha and graft versus host disease following allogeneic bone marrow transplantation.
    Robinet E; Pico JL; Ibrahim A; Ostronoff M; Zambon E; Zohar M; Truneh A; Gay F; Hayat M; Chouaib S
    Bone Marrow Transplant; 1991; 7 Suppl 2():148. PubMed ID: 1652325
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer.
    Barber MD; Fearon KC; Ross JA
    Clin Sci (Lond); 1999 Jan; 96(1):83-7. PubMed ID: 9857110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial measurements of interleukin-6, interleukin-8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients.
    George JF; Kirklin JK; Naftel DC; Bourge RC; White-Williams C; McGiffin DC; Savunen T; Everson MP
    J Heart Lung Transplant; 1997 Oct; 16(10):1046-53. PubMed ID: 9361247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of interferon-gamma production deficiency after autologous and allogeneic stem cell transplantation for malignancies.
    Hanenberg H; Dilloo D; Laws HJ; Zessack N; Heyll A; Burdach S
    Exp Hematol; 1995 Dec; 23(14):1543-52. PubMed ID: 8542945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kinetics of circulating cytokines including IL-6, TNF-alpha, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation.
    Min CK; Lee WY; Min DJ; Lee DG; Kim YJ; Park YH; Kim HJ; Lee S; Kim DW; Lee JW; Min WS; Kim CC
    Bone Marrow Transplant; 2001 Nov; 28(10):935-40. PubMed ID: 11753547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity.
    Turan B; Gallati H; Erdi H; Gürler A; Michel BA; Villiger PM
    J Rheumatol; 1997 Jan; 24(1):128-32. PubMed ID: 9002023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokines and the acute-phase response in clinical bone marrow transplantation.
    Cohen J; Bayston K
    Eur Cytokine Netw; 1990; 1(4):251-5. PubMed ID: 1716489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A possible association between the presence of interleukin-4-secreting cells and a reduction in the risk of acute graft-versus-host disease.
    Takabayashi M; Kanamori H; Takasaki H; Yamaji S; Koharazawa H; Taguchi J; Tomita N; Fujimaki K; Fujisawa S; Maruta A; Ishigatsubo Y
    Exp Hematol; 2005 Feb; 33(2):251-7. PubMed ID: 15676220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.